Hedge Fund Wagers Million on Biotech After FDA Milestone
A major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
Tax efficiency in dividend ETFs comes from efficient distributions and holdings. Grasp the basics to maximize after-tax returns in your plan.
17,061 articlesA major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
When a hedge fund makes a substantive move in Genpact, it prompts investors to reassess the stock. This article break...
Susquehanna lifts Baidu's price target to $140 while maintaining a Neutral rating, citing AI Cloud strength but ongoi...
A new wave of headlines around Nebius stock is stirring debate among investors. This guide breaks down what the news ...
A synthetic contract puts SpaceX at a $2.4 trillion implied IPO, a figure that dwarfs Facebook's listing and tests ho...
The House rejected a bill to fund the Smithsonian American Women’s History Museum, triggering a partisan clash that l...
A six-page FDA memo quietly opens the door for certain nicotine products to reach the market before complete regulato...
A billionaire shifted away from cloud giants to AI infrastructure plays. This article explains what drove the move an...
A $10.2 billion hidden revenue stream from data-center power equipment is quietly driving the AI infrastructure boom....
What makes a beaten-down stock worth a closer look? This article breaks down the signs, runs a hypothetical comeback ...
Marvell Technology’s stock seesaws as AI demand accelerates its growth outlook, even as investors weigh cyclical chip...
In 2026, adjustable-rate HECMs offer borrowers the option to make payments with reverse loans, boosting liquidity whi...